John L. Villano, Md, Phd

This study tested whether adding the drug pembrolizumab to standard chemotherapy could help patients with a type of lung cancer that had spread to their brain but wasn't causing symptoms. The goal was to see if this approach could control the cancer in the brain and body, help pa…